Table 1.
Detection of CTX-M-15 ESBL genes by the amplicon-based next-generation sequencing method (NGS) on direct patient material, compared to conventional method (culture + CDT, followed by microarray).
Phenotypic/Microarray Method | Total | ||
---|---|---|---|
No. (%) Positive | No. (%) Negative | ||
NGS positive | 22 (84.6) | 1 (0.8) | 23 (100) |
NGS negative | 4 (15.4) | 122 (99.2) | 126 (100) |
Total | 26 (100) | 123 (100) | 149 (100) |